The decrease in ovarian cancer rates in the United States accelerated after a marked decline in use of hormone therapy nationwide, study results showed.
“To the best of our knowledge, we do not know of any other calendar-period changes with a similar temporal relationship,” Hannah P. Yang, PhD, ScM, staff scientist at the NCI, told HemOnc Today. “While cause-and-effect relationships cannot be established in our descriptive epidemiological analysis, we can report the compelling temporal association between a precipitous decline in menopausal hormone therapy and a sharp drop in ovarian cancer incidence.”Full Story »
Endocrine Today, May 2013
Personalize your page!
Register for Healio to get content tailored to your specialty and areas of interest.
It’s FREE and only takes one minute.